when were glp-1 agonists approved for weight loss Medications Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Comparing GLP-type therapies for weight

Biochem Biophys Res Commun 2018;505:523-9.ArticlePubMed 63

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

9 Other similar case reports prompted a retrospective analysis of endoscopy data and found a 5-fold increase in risk for residual gastric volume in those who take semaglutide even after appropriate fasting times

Differential regulation of the glucagon and insulin I gene promoters by the basic helix-loop-helix transcription factors E47 and BETA2

As we mentioned before, GLP-1R agonism is able to ameliorate neuroinflammation and behavioral deficits induced by hepatectomy or neuropathic pain (63, 64)

380 Firstly, the expression of GLP-1R is enhanced in the inflamed muscle fibers under pathological conditions, revealing the critical role of GLP-1R in regulating the muscles response to inflammation